The Right to Stay Alive?
dc.contributor.advisor | Hutt, Peter Barton | en_US |
dc.contributor.author | Blot, Madeleine | en_US |
dc.date.accessioned | 2012-06-07T04:57:36Z | |
dc.date.issued | 1998 | en_US |
dc.identifier.citation | The Right to Stay Alive? (1998 Third Year Paper) | en |
dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846801 | |
dc.description.abstract | While standing by my belief that FDA "can't help" infringing on the right of terminally-ill individuals, I will argue that the matter should be removed from FDA's jurisdiction altogether, and evaluated in a constitutional setting where it more properly belongs. Before I move on to a discussion of why I believe that the question of whether the terminally-ill should have access to unapproved but potentially life-saving drugs should be dealt with as a constitutional matter, I will briefly discuss why I believe that it should not be dealt with by the FDA. | en |
dc.language.iso | en_US | en |
dash.license | LAA | en_US |
dc.subject | Food and Drug Law | en |
dc.subject | philosophy of regulation | en |
dc.subject | terminal illness | en |
dc.subject | unapproved drugs | en |
dc.title | The Right to Stay Alive? | en |
dc.type | Paper (for course/seminar/workshop) | en_US |
dc.date.available | 2012-06-07T04:57:36Z | |
dash.authorsordered | false |
Files in this item
This item appears in the following Collection(s)
-
HLS Student Papers [498]